This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Top ETF Stories of May
by Sanghamitra Saha
Inside the top ETF stories of May 2017.
5 Best Tech Stocks for Momentum Investors Right Now
by Zacks Equity Research
Finding the right momentum stocks is not easy due to market volatility, but if executed properly, momentum stocks can bring in hefty returns.
EMQQ -- How This Little-Known ETF Beat Amazon
by Sanghamitra Saha
Emerging market tech ETF EMQQ beats Amazon this year. What made this possible?
Invest Like Warren Buffett with These ETF Strategies
by Sanghamitra Saha
Want to use Buffett's insight? Follow these ETF strategies.
Tech ETFs to Buy on Solid Facebook Q1 Results
by Sweta Killa
While Facebook smashed our top and bottom line estimates buoyed by its fast-growing mobile advertising business, it continued to caution on slowdown in advertising revenues growth this year.
Trump's First 100 Days: 5 Must See ETF Charts
by Neena Mishra
Let's take a look at how various asset classes performed during President Trump's first 100 days in office.
ETFs in Focus After Alphabet's Impressive Q1 Show
by Shubham Jaipuria
Alphabet Inc released its earnings, beating both EPS and revenue estimates.
The Zacks Analyst Blog Highlights: Select Sector SPDR Technology ETF, Vanguard Information Technology ETF, iShares Dow Jones US Technology ETF and MSCI Information Technology Index ETF
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Select Sector SPDR Technology ETF, Vanguard Information Technology ETF, iShares Dow Jones US Technology ETF and MSCI Information Technology Index ETF
Is the Incredible Run for Semiconductor Stocks Over?
by Zacks Equity Research
The negative divergence seen in April has now raised a question in investors' minds -- Is the incredible run for semiconductor stocks over? No, Certainly Not.
5 Stocks that Chaperoned Nasdaq to Double-Digit Gains in Q1
by Zacks Equity Research
The tech-heavy index, Nasdaq, outperformed and recorded a gain of 10% in the first quarter.